Received Jun 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Inadvertent Administration of Only the Prefilled Syringe of the Liquid MenB Component of Penmenvy to a patient.; Inadvertent Administration of Only the Prefilled Syringe of the Liquid MenB Component of Penmenvy to a patient.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Men ABCWY NVS (Penmenvy) suspension for injection in pre-filled syringe for prophylaxis. In JUN-2026, the patient received Penmenvy. In JUN-2026, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: Inadvertent Administration of Only the Prefilled Syringe of the Liquid MenB Component of Penmenvy to a patient.) and inappropriate dose of vaccine administered (Verbatim: Inadvertent Administration of Only the Prefilled Syringe of the Liquid MenB Component of Penmenvy to a patient.). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-JUN-2026 The batch number was not provided upon follow- up with the reporter.